American College of Cardiology

BONOW ET AL., ACC/AHA TASK FORCE REPORT
JACC Vol. 32, No. 5, November 1998:1486-1588

ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease

A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease)

Tables

Table 1   Classification of Cardiac Murmurs

Table 2   Interventions Used to Alter the Intensity of Cardiac Murmurs

Table 3   Factors That Differentiate the Various Causes of Left Ventricular Outflow Tract Obstruction

Table 4   Endocarditis Prophylaxis for Dental Procedures (36)

Table 5   Endocarditis Prophylaxis for Nondental Procedures (36)

Table 6   Endocarditis Prophylaxis Regimens for Dental, Oral, Respiratory Tract, or Esophageal Procedures (36)

Table 7   Endocarditis Prophylaxis Regimens for Genitourinary/Gastrointestinal (Excluding Esophageal) Procedures (36)

Table 8   Primary Prevention of Rheumatic Fever (40)

Table 9   Secondary Prevention of Rheumatic Fever (40)

Table 10   Duration of Secondary Rheumatic Fever Prophylaxis (40)

Table 11   Studies of the Natural History of Asymptomatic Patients With Aortic Stenosis

Table 12   Preoperative Predictors of Surgical Outcome in Aortic Regurgitation

Table 13   Factors Predictive of Reduced Postoperative Survival and Recovery of Left Ventricular Function in Patients With Aortic Regurgitation and Preoperative Left Ventricular Systolic Dysfunction

Table 14   Studies of the Natural History of Asymptomatic Patients With Aortic Regurgitation

Table 15   Natural History of Aortic Regurgitation

Table 16   Randomized Trials of Percutaneous Mitral Balloon Valvotomy and Surgical Commissurotomy

Table 17   Echocardiographic Prediction of Outcome of Percutaneous Mitral Balloon Valvotomy

Table 18   Classification of Mitral Valve Prolapse

Table 19   Use of Echocardiography for Risk Stratification in Mitral Valve Prolapse

Table 20   Preoperative Predictors of Surgical Outcome in Mitral Regurgitation

Table 21   Duke Criteria* for Clinical Diagnosis of Ineffective Endocarditis

Table 22   Native Valve Endocarditis Involving Penicillin-Susceptible Streptococcus viridans and Streptococcus bovis (Minimum Inhibitory Concentration ≤0.1 μg/mL)*

Table 23   Native Valve Endocarditis Involving Streptococcus viridans and Streptococcus bovis Relatively Resistant to Penicillin G (Minimum Inhibitory Concentration >0.1 μg/mL and <0.5 μg/mL)*

Table 24   Standard Therapy for Endocarditis Due to Enterococci*

Table 25   Endocarditis Due to Staphylococcus in the Absence of Prosthetic Material*

Table 26   Endocarditis Due to Staphylococcus in the Presence of a Prosthetic Valve or Other Prosthetic Material*

Table 27   Therapy for Endocarditis Due to HACEK Microorganisms (Haemophilus parainfluenzae, Haemophilus aphrophilus, Actinobacillus actinomycetemcomitans, Cardiobacterium Hominis, Eikenella corrodens, and Kingella kingae)*

Table 28   Fungal Endocarditis and Culture-Negative Endocarditis*

Table 29   Valvular Heart Lesions Associated With High Maternal and/or Fetal Risk During Pregnancy

Table 30   Valvular Heart Lesions Associated With Low Maternal and Fetal Risk During Pregnancy

Table 31   Effects of Cardiovascular Drugs Taken During Pregnancy

Table 32   FDA-Approved Prosthetic Heart Valves

Table 33   Probability of Death Due to Any Cause, Any Valve-Related Complications, and Individual Valve-Related Complications 11 Years After Randomization

Table 34   Antithrombotic Therapy: Prosthetic Heart Valves

Table 35   Antithrombotic Therapy in Patients Requiring Noncardiac Surgery/Dental Care

Table 36   Structural Valve Deterioration of Bioprosthetic Valves

Figures

Figure 1   Strategy for evaluating heart murmurs. *If an ECG or chest x-ray has been obtained and is abnormal, an echocardiogram is recommended.

Figure 2   Management strategy for patients with chronic severe aortic regurgitation.

Figure 3   Management strategy for patients with mitral stenosis.

Figure 4   Management strategy for patients with mitral stenosis and mild symptoms.

Figure 5   Management strategy for patients with mitral stenosis and moderate to severe symptoms.

Figure 6   Management strategy for patients with chronic severe mitral regurgitation.

© 1998 American College of Cardiology and American Heart Association, Inc.
Published by Elsevier Science Inc.